JW Pharmaceutical Corporation (001060.KS) — Stock Score Summary

JW Pharmaceutical Corporation (001060.KS) has a MoatMap StockRank of 99/100 based on Quality (78/100), Value (72/100), and Momentum (50/100) factor scores. The current signal is STRONG BUY. JW Pharmaceutical is a South Korean pharmaceutical firm focused on basic infusions and generic drugs. It lacks the high-margin, proprietary CDMO pricing power and regulatory moats we are targeting in healthcare.

JW Pharmaceutical Corporation is a leading South Korean pharmaceutical company specializing in essential intravenous (IV) fluids, cardiovascular drugs, and specialized therapeutics. The company holds a dominant, near-monopolistic position in the domestic basic IV fluid market, which serves as a highly stable revenue foundation. Additionally, JW Pharmaceutical is recognized for its advanced R&D pipeline focusing on innovative targeted therapies for cancer and immunology.

Key Financial Metrics

Price$17.21
Market Cap$427M
P/E (TTM)10.32
Price/Book1.60
Return on Equity20.1%
Return on Invested Capital23.5%
Debt/Equity14.18
Gross Margin47.3%
Operating Margin16.8%
Revenue Growth7.9%
Dividend Yield2.5%
Free Cash Flow$27K

JW Pharmaceutical Corporation operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is JW Pharmaceutical Corporation’s (001060.KS) StockRank?
MoatMap’s StockRank for JW Pharmaceutical Corporation (001060.KS) is 99/100, with a Strong Buy signal. It is a composite of Quality (78), Value (72), and Momentum (50) factor ranks across MoatMap’s 19,000+ stock universe.
Does JW Pharmaceutical Corporation have an economic moat?
JW Pharmaceutical Corporation (001060.KS) has a Quality factor score of 78/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is JW Pharmaceutical Corporation a buy, hold, or sell?
MoatMap’s current signal for JW Pharmaceutical Corporation (001060.KS) is Strong Buy, based on a StockRank of 99/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is JW Pharmaceutical Corporation in?
JW Pharmaceutical Corporation (001060.KS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (South Korea).
Browse all ranked stocks001060.KS deep dive reportAI ChampionsHow we score stocksSense-check another stock